+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)

Body Fat Reduction Market by Procedure Type, Gender, and End User: Global Opportunity Analysis and Industry Forecast, 2021-2030

  • PDF Icon

    Report

  • 234 Pages
  • October 2021
  • Region: Global
  • Allied Market Research
  • ID: 5521518
The global body fat reduction market was valued at $7,587.77 million in 2020, and is projected to reach $13,910.63 million by 2030, registering a CAGR of 7.5% from 2021 to 2030.



Body fat is commonly the accumulation of adipose tissue, a complex connective tissue with specialized roles in metabolism and endocrine function. Body fat reduction, in the context of medicine, health, or physical fitness, refers to decrease in total body mass caused by loss of fluid, body fat adipose tissue, or lean mass, notably bone mineral deposits, muscle, tendon, and other connective tissue. Body fat removal techniques are often utilized in cosmetic surgery to eliminate excess adipose tissues or fats from the body either by a surgical or a non-surgical procedure.

Higher percentage of body fat leads to weight gain in individuals and further leads to obesity. Obesity is a complicated illness characterized by excess of body fat. Obesity is more than simply an aesthetic issue. It is a medical condition that raises the chance of developing other diseases and health issues, such as heart disease, diabetes, high blood pressure, and some malignancies. Obesity in males is defined as a proportion of body fat more than 25%, with 21-25% considered borderline. Obesity is defined as having a body mass index (BMI) of greater than 33% in women. The higher the proportion of body fat, the more probable is it to develop obesity-related diseases such as cardiac diseases, hypertension, higher chances of having a stroke, and type 2 diabetes.

According to the World Health Organization (WHO), most of the world's population live in countries where overweight and obesity kills more people than underweight individuals and 39 million children under the age of 5 were overweight or obese in 2020 globally. Overweight and obesity, formerly thought to be a problem only in high-income nations, are now on the rise in low and middle income countries, particularly in metropolitan areas. In Africa, the number of overweight children under 5 has increased by nearly 24% since 2000. Almost half of the children under 5 who were overweight or obese in 2019 live in Asia.

Growth of the global body fat reduction market is majorly driven by rise in consumption of carbohydrate-based foods, packaged foods, poor eating habits, and unhealthy lifestyle among young generation as well adults thus leading to weight gain and further obesity. Furthermore, according to the World Obesity Federation if the current trends continue, it is estimated that approximately 2.7 billion adults will be overweight, over 1 billion affected by obesity, and 177 million adults severely affected by obesity by 2025. Thus, surge in obesity population is expected to boost the body fat reduction market.

Moreover, rise in demand for aesthetic enhancement procedures such as cryolipolysis, laser lipolysis, liposuction, tummy tuck also known as abdominoplasty, ultrasound, injectable treatments, red light therapy, and others, owing to self-consciousness among the population, especially in women for beautification is on the rise. According to the American Society of Plastic Surgeons (ASPS) report in 2020, it is estimated that in America 15.6 million of cosmetic procedures were performed among which there were 2.3 million cosmetic surgical procedures and 13.2 million cosmetic minimally-invasive procedures. In addition, approximately $16.7 billion was spent on cosmetic procedures in the U.S.

In contrast, these procedures led to certain complications such as seroma, infections, necrosis as well as hematoma (bleeding under the skin), lumpy and uneven results, persistent numbness that can last for months, changes in skin color in the treated areas, pulmonary edema and others. Lack of reimbursement from insurance companies and high cost of the procedure is also a factor that may hinder the growth of the market. Technological advancements for body contouring like the cool sculpting and various innovation of such technologies is a great opportunity for the key players to invest in the emerging markets.

Furthermore, the COVID-19 pandemic resulted in a decrease in body fat reduction procedures globally, but the closure of parks, fitness centers, educational institutions, and the operation of work from home (WFH) culture resulted in an increase in weight gain issues and obesity cases, which is expected to boost market growth during the forecast period.

The body fat reduction market is segmented on the basis of procedure type, gender, end user, and region. On the basis of procedure type, the market is categorized into surgical and non-surgical. The surgical segment is further categorized into liposuction and abdominoplasty. Moreover, the non-surgical segment is subdivided into cryolipolysis, ultrasound, and others. On the basis of gender, the market is segregated into male and female. By end user, it is fragmented into hospitals & clinics, medical spas, and others.

Region wise, the market is analyzed across North America (the U.S., Canada, and Mexico), Europe (Germany, France, the UK, Italy, Spain, and rest of Europe), Asia-Pacific (Japan, China, India, Australia, South Korea and rest of Asia-Pacific), and LAMEA (Brazil, South Africa, Saudi Arabia, and rest of LAMEA).

Some of the major companies that operate in the global body fat reduction market are AbbVie Inc. (Allergan Inc.), Apollo Hospitals Enterprise Limited (Apollo Cosmetic Clinics), Bausch Health Companies Inc. (Solta Medical International Inc.), Candela Medical, Cutera Inc., Cynosure, Llc., Lumenis, Ltd., Sciton, Inc., Sisram Medical Ltd (Alma Lasers Ltd.) and VLCC Health Care Ltd.

KEY BENEFITS FOR STAKEHOLDERS

  • This report provides an extensive analysis of the current and emerging market trends and dynamics in the global body fat reduction market to identify the prevailing opportunities.
  • This study presents the competitive landscape of the global market to predict the competitive environment across geographies.
  • Comprehensive analysis of factors that drive and restrict the market growth is provided.
  • Region- & country-wise analysis is provided to understand the market trends and dynamics.

KEY MARKET SEGMENTS


By Procedure

  • Surgical
  • Liposuction
  • Abdominoplasty
  • Non-Surgical
  • Cryolipolysis
  • Ultrasound
  • Others

By Gender

  • Male
  • Female

By End User

  • Hospitals & Clinics
  • Medical spas
  • Others

By Region

  • North America
  • U.S.
  • Canada
  • Mexico
  • Europe
  • Germany
  • France
  • UK
  • Italy
  • Spain
  • Rest of Europe
  • Asia-Pacific
  • Japan
  • China
  • India
  • Australia
  • South Korea
  • Rest of Asia-Pacific
  • LAMEA
  • Brazil
  • South Africa
  • Saudi Arabia
  • Rest of LAMEA

KEY MARKET PLAYERS

  • AbbVie Inc. (Allergan Inc.)
  • Apollo Hospitals Enterprise Limited (Apollo Cosmetic Clinics)
  • Bausch Health Companies Inc. (Solta Medical International Inc.)
  • Candela Medical
  • Cutera Inc.
  • Cynosure, Llc.
  • Lumenis, Ltd.
  • Sciton, Inc.
  • Sisram Medical Ltd (Alma Lasers Ltd.)
  • VLCC Health Care Ltd.

Table of Contents

CHAPTER 1: INTRODUCTION
1.1. Report description
1.2. Key benefits for stakeholders
1.3. Key market segments
1.3.1. List of key players profiled in the report
1.4. Research methodology
1.4.1. Secondary research
1.4.2. Primary research
1.4.3. Analyst tools and models
CHAPTER 2: EXECUTIVE SUMMARY
2.1. Key findings of the study
2.2. CXO perspective
CHAPTER 3: MARKET LANDSCAPE
3.1. Market definition and scope
3.2. Key findings
3.2.1. Top investment pockets
3.2.2. Top winning strategies
3.3. Porter’s five force analysis
3.4. Top player positioning, 2020
3.5. Market dynamics
3.5.1. Drivers
3.5.1.1. Increasing prevalence of obesity
3.5.1.2. Growing focus on aesthetics and cosmetic surgeries
3.5.1.3. Technological advancements and rise in adoption of minimally invasive procedures
3.5.2. Restraint
3.5.2.1. High cost of procedures coupled with post treatment complications
3.5.3. Opportunity
3.5.3.1. New developments and increasing number of facilities offering fat reduction services
3.5.4. Impact analysis
3.6. COVID-19 impact analysis on the body fat reduction market
CHAPTER 4: BODY FAT REDUCTION MARKET, BY PROCEDURE
4.1. Overview
4.1.1. Market size and forecast
4.2. Surgical
4.2.1. Key market trends, growth factors, and opportunities
4.2.2. Market size and forecast, by region
4.2.3. Market analysis, by country
4.2.4. Market size and forecast, by type
4.2.4.1. Liposuction
4.2.4.1.1. Market size and forecast
4.2.4.2. Abdominoplasty
4.2.4.2.1. Market size and forecast
4.3. Non-Surgical
4.3.1. Key market trends, growth factors, and opportunities
4.3.2. Market size and forecast, by region
4.3.3. Market analysis, by country
4.3.4. Market size and forecast, by type
4.3.4.1. Cryolipolysis
4.3.4.1.1. Market size and forecast
4.3.4.2. Ultrasound
4.3.4.2.1. Market size and forecast
4.3.4.3. Others
4.3.4.3.1. Market size and forecast
CHAPTER 5: BODY FAT REDUCTION MARKET, BY GENDER
5.1. Overview
5.1.1. Market size and forecast
5.2. Male
5.2.1. Market size and forecast, by region
5.2.2. Market analysis, by country
5.3. Female
5.3.1. Market size and forecast, by region
5.3.2. Market analysis, by country
CHAPTER 6: BODY FAT REDUCTION MARKET, BY END USER
6.1. Overview
6.1.1. Market size and forecast
6.2. Hospitals & clinics
6.2.1. Market size and forecast, by region
6.2.2. Market analysis, by country
6.3. Medical spas
6.3.1. Market size and forecast, by region
6.3.2. Market analysis, by country
6.4. Others
6.4.1. Market size and forecast, by region
6.4.2. Market analysis, by country
CHAPTER 7: BODY FAT REDUCTION MARKET, BY REGION
7.1. Overview
7.1.1. Market size and forecast
7.2. North America
7.2.1. Key market trends, growth factors, and opportunities
7.2.2. North America Body fat reduction market, by Procedure
7.2.3. North America Body fat reduction market, by Gender
7.2.4. North America Body fat reduction market, by End User
7.2.5. Market size and forecast, by country
7.2.5.1. U.S.
7.2.5.1.1. U.S. Body fat reduction market, by Procedure
7.2.5.1.2. U.S. Body fat reduction market, by Gender
7.2.5.1.3. U.S. Body fat reduction market, by End User
7.2.5.2. Canada
7.2.5.2.1. Canada Body fat reduction market, by Procedure
7.2.5.2.2. Canada Body fat reduction market, by Gender
7.2.5.2.3. Canada Body fat reduction market, by End User
7.2.5.3. Mexico
7.2.5.3.1. Mexico Body fat reduction market, by Procedure
7.2.5.3.2. Mexico Body fat reduction market, by Gender
7.2.5.3.3. Mexico Body fat reduction market, by End User
7.3. Europe
7.3.1. Key market trends, growth factors, and opportunities
7.3.2. Europe Body fat reduction market, by procedure
7.3.3. Europe Body fat reduction market, by gender
7.3.4. Europe Body fat reduction market, by end user
7.3.5. Market size and forecast, by country
7.3.5.1. Germany
7.3.5.1.1. Germany Body fat reduction market, by Procedure
7.3.5.1.2. Germany Body fat reduction market, by Gender
7.3.5.1.3. Germany Body fat reduction market, by End User
7.3.5.2. France
7.3.5.2.1. France Body fat reduction market, by Procedure
7.3.5.2.2. France Body fat reduction market, by Gender
7.3.5.2.3. France Body fat reduction market, by End User
7.3.5.3. UK
7.3.5.3.1. UK Body fat reduction market, by Procedure
7.3.5.3.2. UK Body fat reduction market, by Gender
7.3.5.3.3. UK Body fat reduction market, by End User
7.3.5.4. Italy
7.3.5.4.1. Italy Body fat reduction market, by procedure
7.3.5.4.2. Italy Body fat reduction market, by Gender
7.3.5.4.3. Italy Body fat reduction market, by end user
7.3.5.5. Spain
7.3.5.5.1. Spain Body fat reduction market, by Procedure
7.3.5.5.2. Spain Body fat reduction market, by Gender
7.3.5.5.3. Spain Body fat reduction market, by end user
7.3.5.6. Rest of Europe
7.3.5.6.1. Rest of Europe Body fat reduction market, by Procedure
7.3.5.6.2. Rest of Europe Body fat reduction market, by Gender
7.3.5.6.3. Rest of Europe Body fat reduction market, by End User
7.4. Asia-Pacific
7.4.1. Key market trends, growth factors, and opportunities
7.4.2. Asia-Pacific Body fat reduction market, by procedure
7.4.3. Asia-Pacific Body fat reduction market, by gender
7.4.4. Asia-Pacific Body fat reduction market, by End User
7.4.5. Market size and forecast, by country
7.4.5.1. Japan
7.4.5.1.1. Japan Body fat reduction market, by Procedure
7.4.5.1.2. Japan Body fat reduction market, by Gender
7.4.5.1.3. Japan Body fat reduction market, by end user
7.4.5.2. China
7.4.5.2.1. China Body fat reduction market, by Procedure
7.4.5.2.2. China Body fat reduction market, by Gender
7.4.5.2.3. China Body fat reduction market, by end user
7.4.5.3. Australia
7.4.5.3.1. Australia Body fat reduction market, by procedure
7.4.5.3.2. Australia Body fat reduction market, by Gender
7.4.5.3.3. Australia Body fat reduction market, by End User
7.4.5.4. India
7.4.5.4.1. India Body fat reduction market, by Procedure
7.4.5.4.2. India Body fat reduction market, by Gender
7.4.5.4.3. India Body fat reduction market, by end user
7.4.5.5. South Korea
7.4.5.5.1. South Korea Body fat reduction market, by procedure
7.4.5.5.2. South Korea Body fat reduction market, by gender
7.4.5.5.3. South Korea Body fat reduction market, by End User
7.4.5.6. Rest of Asia-Pacific
7.4.5.6.1. Rest of Asia-Pacific Body fat reduction market, by Procedure
7.4.5.6.2. Rest of Asia-Pacific Body fat reduction market, by Gender
7.4.5.6.3. Rest of Asia-Pacific Body fat reduction market, by End User
7.5. LAMEA
7.5.1. Key market trends, growth factors, and opportunities
7.5.2. LAMEA Body fat reduction market, by procedure
7.5.3. LAMEA Body fat reduction market, by gender
7.5.4. LAMEA Body fat reduction market, by end user
7.5.5. Market size and forecast, by country
7.5.5.1. Brazil
7.5.5.1.1. Brazil Body fat reduction market, by Procedure
7.5.5.1.2. Brazil Body fat reduction market, by gender
7.5.5.1.3. Brazil Body fat reduction market, by end user
7.5.5.2. Saudi Arabia
7.5.5.2.1. Saudi Arabia Body fat reduction market, by procedure
7.5.5.2.2. Saudi Arabia Body fat reduction market, by Gender
7.5.5.2.3. Saudi Arabia Body fat reduction market, by End User
7.5.5.3. South Africa
7.5.5.3.1. South Africa Body fat reduction market, by Procedure
7.5.5.3.2. South Africa Body fat reduction market, by Gender
7.5.5.3.3. South Africa Body fat reduction market, by End User
7.5.5.4. Rest of LAMEA
7.5.5.4.1. Rest of LAMEA Body fat reduction market, by Procedure
7.5.5.4.2. Rest of LAMEA Body fat reduction market, by Gender
7.5.5.4.3. Rest of LAMEA Body fat reduction market, by End User
CHAPTER 8: COMPANY PROFILES
8.1. ABBVIE INC. (ALLERGAN INC.)
8.1.1. Company overview
8.1.2. Company snapshot
8.1.3. Operating business segments
8.1.4. Product portfolio
8.1.5. Business performance
8.1.6. Key strategic moves and developments
8.2. APOLLO HOSPITALS ENTERPRISE LIMITED (APOLLO COSMETIC CLINICS)
8.2.1. Company overview
8.2.2. Company snapshot
8.2.3. Operating business segments
8.2.4. Product portfolio
8.2.5. Business performance
8.3. BAUSCH HEALTH COMPANIES INC. (SOLTA MEDICAL INTERNATIONAL INC.)
8.3.1. Company overview
8.3.2. Company snapshot
8.3.3. Operating business segments
8.3.4. Product portfolio
8.3.5. Business performance
8.4. CANDELA MEDICAL
8.4.1. Company overview
8.4.2. Company snapshot
8.4.3. Operating business segments
8.4.4. Product portfolio
8.5. CUTERA INC.
8.5.1. Company overview
8.5.2. Company snapshot
8.5.3. Operating business segments
8.5.4. Product portfolio
8.5.5. Business performance
8.5.6. Key strategic moves and developments
8.6. CYNOSURE, LLC.
8.6.1. Company overview
8.6.2. Company snapshot
8.6.3. Operating business segments
8.6.4. Product portfolio
8.6.5. Key strategic moves and developments
8.7. LUMENIS LTD.
8.7.1. Company overview
8.7.2. Company snapshot
8.7.3. Operating business segments
8.7.4. Product portfolio
8.7.5. Key strategic moves and developments
8.8. SCITON, INC.
8.8.1. Company overview
8.8.2. Company snapshot
8.8.3. Operating business segments
8.8.4. Product portfolio
8.8.5. Key strategic moves and developments
8.9. SISRAM MEDICAL LTD (ALMA LASERS LTD.)
8.9.1. Company overview
8.9.2. Company snapshot
8.9.3. Operating business segments
8.9.4. Product portfolio
8.9.5. Business performance
8.9.6. Key strategic moves and developments
8.10. VLCC HEALTH CARE LTD.
8.10.1. Company overview
8.10.2. Company snapshot
8.10.3. Operating business segments
8.10.4. Product portfolio
8.10.5. Business performance
List of Tables
TABLE 01. BODY FAT REDUCTION MARKET, PROCEDURE, 2020-2030 ($MILLION)
TABLE 02. SURGICAL BODY FAT REDUCTION MARKET, BY REGION, 2020-2030 ($MILLION)
TABLE 03. BODY FAT REDUCTION SURGICAL MARKET, BY TYPE, 2020-2030 ($MILLION)
TABLE 04. BODY FAT REDUCTION NON-SURGICAL MARKET, BY REGION, 2020-2030 ($MILLION)
TABLE 05. BODY FAT REDUCTION NON-SURGICAL MARKET, BY TYPE, 2020-2030 ($MILLION)
TABLE 06. BODY FAT REDUCTION MARKET, BY GENDER, 2020-2030 ($MILLION)
TABLE 07. MALE BODY FAT REDUCTION MARKET, BY REGION, 2020-2030 ($MILLION)
TABLE 08. FEMALE BODY FAT REDUCTION MARKET, BY REGION, 2020-2030 ($MILLION)
TABLE 09. BODY FAT REDUCTION MARKET, BY END USER, 2020-2030 ($MILLION)
TABLE 10. BODY FAT REDUCTION MARKET FOR HOSPITALS & CLINICS, BY REGION, 2020-2030 ($MILLION)
TABLE 11. BODY FAT REDUCTION MARKET FOR MEDICAL SPAS, BY REGION, 2020-2030 ($MILLION)
TABLE 12. BODY FAT REDUCTION MARKET FOR OTHERS, BY REGION, 2020-2030 ($MILLION)
TABLE 13. BODY FAT REDUCTION MARKET, BY REGION, 2020-2030 ($MILLION)
TABLE 14. NORTH AMERICA BODY FAT REDUCTION MARKET, BY PROCEDURE, 2020-2030 ($MILLION)
TABLE 15. NORTH AMERICA BODY FAT REDUCTION MARKET, BY GENDER, 2020-2030 ($MILLION)
TABLE 16. NORTH AMERICA BODY FAT REDUCTION MARKET, BY END USER, 2020-2030 ($MILLION)
TABLE 17. NORTH AMERICA BODY FAT REDUCTION MARKET, BY COUNTRY, 2020-2030 ($MILLION)
TABLE 18. U.S. BODY FAT REDUCTION MARKET, BY PROCEDURE, 2020-2030 ($MILLION)
TABLE 19. U.S. BODY FAT REDUCTION MARKET, BY GENDER, 2020-2030 ($MILLION)
TABLE 20. U.S. BODY FAT REDUCTION MARKET, BY END USER, 2020-2030 ($MILLION)
TABLE 21. CANADA BODY FAT REDUCTION MARKET, BY PROCEDURE, 2020-2030 ($MILLION)
TABLE 22. CANADA BODY FAT REDUCTION MARKET, BY GENDER, 2020-2030 ($MILLION)
TABLE 23. CANADA BODY FAT REDUCTION MARKET, BY END USER, 2020-2030 ($MILLION)
TABLE 24. MEXICO BODY FAT REDUCTION MARKET, BY PROCEDURE, 2020-2030 ($MILLION)
TABLE 25. MEXICO BODY FAT REDUCTION MARKET, BY GENDER, 2020-2030 ($MILLION)
TABLE 26. MEXICO BODY FAT REDUCTION MARKET, BY END USER, 2020-2030 ($MILLION)
TABLE 27. EUROPE BODY FAT REDUCTION MARKET, BY PROCEDURE, 2020-2030 ($MILLION)
TABLE 28. EUROPE BODY FAT REDUCTION MARKET, BY GENDER, 2020-2030 ($MILLION)
TABLE 29. EUROPE BODY FAT REDUCTION MARKET, BY END USER, 2020-2030 ($MILLION)
TABLE 30. EUROPE BODY FAT REDUCTION MARKET, BY COUNTRY, 2020-2030 ($MILLION)
TABLE 31. GERMANY BODY FAT REDUCTION MARKET, BY PROCEDURE, 2020-2030 ($MILLION)
TABLE 32. GERMANY BODY FAT REDUCTION MARKET, BY GENDER, 2020-2030 ($MILLION)
TABLE 33. GERMANY BODY FAT REDUCTION MARKET, BY END USER, 2020-2030 ($MILLION)
TABLE 34. FRANCE BODY FAT REDUCTION MARKET, BY PROCEDURE, 2020-2030 ($MILLION)
TABLE 35. FRANCE BODY FAT REDUCTION MARKET, BY GENDER, 2020-2030 ($MILLION)
TABLE 36. FRANCE BODY FAT REDUCTION MARKET, BY END USER, 2020-2030 ($MILLION)
TABLE 37. UK BODY FAT REDUCTION MARKET, BY PROCEDURE, 2020-2030 ($MILLION)
TABLE 38. UK BODY FAT REDUCTION MARKET, BY GENDER, 2020-2030 ($MILLION)
TABLE 39. UK BODY FAT REDUCTION MARKET, BY END USER, 2020-2030 ($MILLION)
TABLE 40. ITALY BODY FAT REDUCTION MARKET, BY PROCEDURE, 2020-2030 ($MILLION)
TABLE 41. ITALY BODY FAT REDUCTION MARKET, BY GENDER, 2020-2030 ($MILLION)
TABLE 42. ITALY BODY FAT REDUCTION MARKET, BY END USER, 2020-2030 ($MILLION)
TABLE 43. SPAIN BODY FAT REDUCTION MARKET, BY PROCEDURE, 2020-2030 ($MILLION)
TABLE 44. SPAIN BODY FAT REDUCTION MARKET, BY GENDER, 2020-2030 ($MILLION)
TABLE 45. SPAIN BODY FAT REDUCTION MARKET, BY END USER, 2020-2030 ($MILLION)
TABLE 46. REST OF EUROPE BODY FAT REDUCTION MARKET, BY PROCEDURE, 2020-2030 ($MILLION)
TABLE 47. REST OF EUROPE BODY FAT REDUCTION MARKET, BY GENDER, 2020-2030 ($MILLION)
TABLE 48. REST OF EUROPE BODY FAT REDUCTION MARKET, BY END USER, 2020-2030 ($MILLION)
TABLE 49. ASIA-PACIFIC BODY FAT REDUCTION MARKET, BY PROCEDURE, 2020-2030 ($MILLION)
TABLE 50. ASIA-PACIFIC BODY FAT REDUCTION MARKET, BY GENDER, 2020-2030 ($MILLION)
TABLE 51. ASIA-PACIFIC BODY FAT REDUCTION MARKET, BY END USER, 2020-2030 ($MILLION)
TABLE 52. ASIA-PACIFIC BODY FAT REDUCTION MARKET, BY COUNTRY, 2020-2030 ($MILLION)
TABLE 53. JAPAN BODY FAT REDUCTION MARKET, BY PROCEDURE, 2020-2030 ($MILLION)
TABLE 54. JAPAN BODY FAT REDUCTION MARKET, BY GENDER, 2020-2030 ($MILLION)
TABLE 55. JAPAN BODY FAT REDUCTION MARKET, BY END USER, 2020-2030 ($MILLION)
TABLE 56. CHINA BODY FAT REDUCTION MARKET, BY PROCEDURE, 2020-2030 ($MILLION)
TABLE 57. CHINA BODY FAT REDUCTION MARKET, BY GENDER, 2020-2030 ($MILLION)
TABLE 58. CHINA BODY FAT REDUCTION MARKET, BY END USER, 2020-2030 ($MILLION)
TABLE 59. AUSTRALIA BODY FAT REDUCTION MARKET, BY PROCEDURE, 2020-2030 ($MILLION)
TABLE 60. AUSTRALIA BODY FAT REDUCTION MARKET, BY GENDER, 2020-2030 ($MILLION)
TABLE 61. AUSTRALIA BODY FAT REDUCTION MARKET, BY END USER, 2020-2030 ($MILLION)
TABLE 62. INDIA BODY FAT REDUCTION MARKET, BY PROCEDURE, 2020-2030 ($MILLION)
TABLE 63. INDIA BODY FAT REDUCTION MARKET, BY GENDER, 2020-2030 ($MILLION)
TABLE 64. INDIA BODY FAT REDUCTION MARKET, BY END USER, 2020-2030 ($MILLION)
TABLE 65. SOUTH KOREA BODY FAT REDUCTION MARKET, BY PROCEDURE, 2020-2030 ($MILLION)
TABLE 66. SOUTH KOREA BODY FAT REDUCTION MARKET, BY GENDER, 2020-2030 ($MILLION)
TABLE 67. SOUTH KOREA BODY FAT REDUCTION MARKET, BY END USER, 2020-2030 ($MILLION)
TABLE 68. REST OF ASIA-PACIFIC BODY FAT REDUCTION MARKET, BY PROCEDURE, 2020-2030 ($MILLION)
TABLE 69. REST OF ASIA-PACIFIC BODY FAT REDUCTION MARKET, BY GENDER, 2020-2030 ($MILLION)
TABLE 70. REST OF ASIA-PACIFIC BODY FAT REDUCTION MARKET, BY END USER, 2020-2030 ($MILLION)
TABLE 71. LAMEA BODY FAT REDUCTION MARKET, BY PROCEDURE, 2020-2030 ($MILLION)
TABLE 72. LAMEA BODY FAT REDUCTION MARKET, BY GENDER, 2020-2030 ($MILLION)
TABLE 73. LAMEA BODY FAT REDUCTION MARKET, BY END USER, 2020-2030 ($MILLION)
TABLE 74. LAMEA BODY FAT REDUCTION MARKET, BY COUNTRY, 2020-2030 ($MILLION)
TABLE 75. BRAZIL BODY FAT REDUCTION MARKET, BY PROCEDURE, 2020-2030 ($MILLION)
TABLE 76. BRAZIL BODY FAT REDUCTION MARKET, BY GENDER, 2020-2030 ($MILLION)
TABLE 77. BRAZIL BODY FAT REDUCTION MARKET, BY END USER, 2020-2030 ($MILLION)
TABLE 78. SAUDI ARABIA BODY FAT REDUCTION MARKET, BY PROCEDURE, 2020-2030 ($MILLION)
TABLE 79. SAUDI ARABIA BODY FAT REDUCTION MARKET, BY GENDER, 2020-2030 ($MILLION)
TABLE 80. SAUDI ARABIA BODY FAT REDUCTION MARKET, BY END USER, 2020-2030 ($MILLION)
TABLE 81. SOUTH AFRICA BODY FAT REDUCTION MARKET, BY PROCEDURE, 2020-2030 ($MILLION)
TABLE 82. SOUTH AFRICA BODY FAT REDUCTION MARKET, BY GENDER, 2020-2030 ($MILLION)
TABLE 83. SOUTH AFRICA BODY FAT REDUCTION MARKET, BY END USER, 2020-2030 ($MILLION)
TABLE 84. REST OF LAMEA BODY FAT REDUCTION MARKET, BY PROCEDURE, 2020-2030 ($MILLION)
TABLE 85. REST OF LAMEA BODY FAT REDUCTION MARKET, BY GENDER, 2020-2030 ($MILLION)
TABLE 86. REST OF LAMEA BODY FAT REDUCTION MARKET, BY END USER, 2020-2030 ($MILLION)
TABLE 87. ABBVIE: COMPANY SNAPSHOT
TABLE 88. ABBVIE: PRODUCT SEGMENTS
TABLE 89. ABBVIE: PRODUCT PORTFOLIO
TABLE 90. ABBVIE: KEY DEVELOPMENTS
TABLE 91. APOLLO: COMPANY SNAPSHOT
TABLE 92. APOLLO: PRODUCT SEGMENTS
TABLE 93. APOLLO: PRODUCT PORTFOLIO
TABLE 94. BAUSCH: COMPANY SNAPSHOT
TABLE 95. BAUSCH: OPERATING SEGMENTS
TABLE 96. BAUSCH: PRODUCT PORTFOLIO
TABLE 97. CANDELA: COMPANY SNAPSHOT
TABLE 98. CANDELA: OPERATING SEGMENTS
TABLE 99. CANDELA: PRODUCT PORTFOLIO
TABLE 100. CUTERA: COMPANY SNAPSHOT
TABLE 101. CUTERA: OPERATING SEGMENTS
TABLE 102. CUTERA: PRODUCT PORTFOLIO
TABLE 103. CUTERA: KEY DEVELOPMENTS
TABLE 104. CYNOSURE: COMPANY SNAPSHOT
TABLE 105. CYNOSURE: PRODUCT SEGMENTS
TABLE 106. CYNOSURE: PRODUCT PORTFOLIO
TABLE 107. CYNOSURE: KEY DEVELOPMENTS
TABLE 108. LUMENIS: COMPANY SNAPSHOT
TABLE 109. LUMENIS: PRODUCT SEGMENTS
TABLE 110. LUMENIS: PRODUCT PORTFOLIO
TABLE 111. LUMENIS: KEY DEVELOPMENTS
TABLE 112. SCITON: COMPANY SNAPSHOT
TABLE 113. SCITON: OPERATING BUSINESS SEGMENTS
TABLE 114. SCITON: PRODUCT PORTFOLIO
TABLE 115. SCITON: KEY DEVELOPMENTS
TABLE 116. SISRAM: COMPANY SNAPSHOT
TABLE 117. SISRAM: OPERATING SEGMENTS
TABLE 118. SISRAM: PRODUCT PORTFOLIO
TABLE 119. SISRAM: KEY DEVELOPMENTS
TABLE 120. VLCC: COMPANY SNAPSHOT
TABLE 121. VLCC: OPERATING BUSINESS SEGMENTS
TABLE 122. VLCC: PRODUCT PORTFOLIO
List of Figures
FIGURE 01. BODY FAT REDUCTION MARKET SEGMENTATION
FIGURE 02. TOP INVESTMENT POCKETS
FIGURE 03. TOP WINNING STRATEGIES, BY YEAR, 2018-2021
FIGURE 04. TOP WINNING STRATEGIES, BY DEVELOPMENT, 2018-2021 (%)
FIGURE 05. TOP WINNING STRATEGIES, BY COMPANY, 2018-2021
FIGURE 06. HIGH BARGAINING POWER OF SUPPLIERS
FIGURE 07. MODERATE BARGAINING POWER OF BUYERS
FIGURE 08. MODERATE THREAT OF SUBSTITUTES
FIGURE 09. HIGH THREAT OF NEW ENTRANTS
FIGURE 10. HIGH COMPETITIVE RIVALRY
FIGURE 11. TOP PLAYER POSITIONING, 2020
FIGURE 12. IMPACT ANALYSIS
FIGURE 13. COMPARATIVE SHARE ANALYSIS OF BODY FAT REDUCTION SURGICAL MARKET, BY COUNTRY, 2020 & 2030 ($MILLION)
FIGURE 14. BODY FAT REDUCTION LIPOSUCTION MARKET, 2020-2030 ($MILLION)
FIGURE 15. BODY FAT REDUCTION ABDOMINOPLASTY MARKET, 2020-2030 ($MILLION)
FIGURE 16. COMPARATIVE SHARE ANALYSIS OF BODY FAT REDUCTION NON-SURGICAL MARKET, BY COUNTRY, 2020 & 2030 ($MILLION)
FIGURE 17. BODY FAT REDUCTION CRYOLIPOLYSIS MARKET, 2020-2030 ($MILLION)
FIGURE 18. BODY FAT REDUCTION ULTRASOUND MARKET, 2020-2030 ($MILLION)
FIGURE 19. BODY FAT REDUCTION OTHERS MARKET, 2020-2030 ($MILLION)
FIGURE 20. COMPARATIVE SHARE ANALYSIS OF MALE BODY FAT REDUCTION MARKET, BY COUNTRY, 2020 & 2030 ($MILLION)
FIGURE 21. COMPARATIVE SHARE ANALYSIS OF FEMALE BODY FAT REDUCTION MARKET, BY COUNTRY, 2020 & 2030 ($MILLION)
FIGURE 22. COMPARATIVE ANALYSIS OF BODY FAT REDUCTION MARKET FOR HOSPITALS & CLINICS, BY COUNTRY, 2020 & 2030 ($MILLION)
FIGURE 23. COMPARATIVE ANALYSIS OF BODY FAT REDUCTION MARKET FOR MEDICAL SPAS, BY COUNTRY, 2020 & 2030 ($MILLION)
FIGURE 24. COMPARATIVE ANALYSIS OF BODY FAT REDUCTION MARKET FOR OTHERS, BY COUNTRY, 2020 & 2030 ($MILLION)
FIGURE 25. ABBVIE: NET SALES, 2018-2020 ($MILLION)
FIGURE 26. ABBVIE: REVENUE SHARE BY REGION, 2020(%)
FIGURE 27. APOLLO: NET SALES, 2018-2020 ($MILLION)
FIGURE 28. APOLLO: REVENUE SHARE BY SEGMENT, 2020 (%)
FIGURE 29. BAUSCH: NET SALES, 2018-2020 ($MILLION)
FIGURE 30. BAUSCH: REVENUE SHARE BY SEGMENT, 2020 (%)
FIGURE 31. BAUSCH: REVENUE SHARE BY REGION, 2020(%)
FIGURE 32. CUTERA: NET SALES, 2018-2020 ($MILLION)
FIGURE 33. CUTERA: REVENUE SHARE BY SEGMENT, 2020 (%)
FIGURE 34. CUTERA: REVENUE SHARE BY REGION, 2020(%)
FIGURE 35. SISRAM: NET SALES, 2018-2020 ($MILLION)
FIGURE 36. SISRAM: REVENUE SHARE BY SEGMENT, 2020 (%)
FIGURE 37. SISRAM: REVENUE SHARE BY REGION, 2020(%)
FIGURE 38. VLCC: NET SALES, 2019-2021 ($MILLION)
FIGURE 39. VLCC: REVENUE SHARE BY REGION, 2021 (%)

Companies Mentioned

  • AbbVie Inc. (Allergan Inc.)
  • Apollo Hospitals Enterprise Limited (Apollo Cosmetic Clinics)
  • Bausch Health Companies Inc. (Solta Medical International Inc.)
  • Candela Medical
  • Cutera Inc.
  • Cynosure LLC.
  • Lumenis LTD.
  • Sciton Inc.
  • Sisram Medical Ltd (Alma Lasers Ltd.)
  • VLCC Health Care Ltd

Methodology

The analyst offers exhaustive research and analysis based on a wide variety of factual inputs, which largely include interviews with industry participants, reliable statistics, and regional intelligence. The in-house industry experts play an instrumental role in designing analytic tools and models, tailored to the requirements of a particular industry segment. The primary research efforts include reaching out participants through mail, tele-conversations, referrals, professional networks, and face-to-face interactions.

They are also in professional corporate relations with various companies that allow them greater flexibility for reaching out to industry participants and commentators for interviews and discussions.

They also refer to a broad array of industry sources for their secondary research, which typically include; however, not limited to:

  • Company SEC filings, annual reports, company websites, broker & financial reports, and investor presentations for competitive scenario and shape of the industry
  • Scientific and technical writings for product information and related preemptions
  • Regional government and statistical databases for macro analysis
  • Authentic news articles and other related releases for market evaluation
  • Internal and external proprietary databases, key market indicators, and relevant press releases for market estimates and forecast

Furthermore, the accuracy of the data will be analyzed and validated by conducting additional primaries with various industry experts and KOLs. They also provide robust post-sales support to clients.

Loading
LOADING...

Table Information